Cargando…
The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes
Meloxicam (MLX) is a non-steroidal anti-inflammatory drug used to treat rheumatoid arthritis and osteoarthritis. However, its poor water solubility limits the dissolution process and influences absorption. In order to solve this problem and improve its bioavailability, we prepared it in nanocrystals...
Autores principales: | Yu, Yao, Tian, Yang, Zhang, Hui, Jia, Qingxian, Chen, Xuejun, Kang, Dongzhou, Du, Yimeng, Song, Shenghan, Zheng, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780752/ https://www.ncbi.nlm.nih.gov/pubmed/35056734 http://dx.doi.org/10.3390/molecules27020421 |
Ejemplares similares
-
Optimization of the sonication process for meloxicam nanocrystals preparation
por: IURIAN, SONIA, et al.
Publicado: (2015) -
Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects
por: Nagai, Noriaki, et al.
Publicado: (2020) -
Pharmacokinetics of meloxicam in pigeons after single intravenous, oral, and intramuscular administration
por: Chen, Jun-Cheng, et al.
Publicado: (2023) -
In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
por: Chen, Min, et al.
Publicado: (2017) -
Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation
por: Yu, Qin, et al.
Publicado: (2018)